BiotechTube
Home/Noveome Biotherapeutics/Patrick T. Welch
PT

Patrick T. Welch

CEO/Board Member

Noveome Biotherapeutics

Therapeutic Areas

OphthalmologyNeurologyDermatologyGastroenterologyNeonatology

Noveome Biotherapeutics Pipeline

DrugIndicationPhase
ST266Necrotizing Enterocolitis (NEC) in Premature InfantsPhase 1-2

Leadership Team at Noveome Biotherapeutics

LR
Larry R. Brown, Sc.D.
Research & Development Executive Vice President/Chief Scientific Officer
KP
Karin Potoka, MD, FAAP
Chief Medical Officer
View full Noveome Biotherapeutics profile